May 7, 2024 News by Margarida Maia, PhD Wayne State professor wins grant to study oligodendrocytes in MS Alexander Gow, PhD, a professor at Wayne State University School of Medicine in Detroit, has been awarded a grant to study how stressed oligodendrocytes, the cells that produce myelin in the brain and spinal cord, could be at the origin of multiple sclerosis (MS). The three-year, $644,827 grant from…
May 6, 2024 News by Marisa Wexler, MS Nearly $650k awarded to advance potential remyelination drug IFB-048 The National Multiple Sclerosis Society has awarded Inflectis BioScience a grant valued at $649,601 to advance the preclinical development of IFB-048, the company’s experimental treatment to promote myelin repair in multiple sclerosis (MS). “This grant along with the support from the Society are a testimony…
May 3, 2024 News by Steve Bryson, PhD Charles River to help FibroBiologics produce 3D cell-based therapies Charles River Laboratories has joined up with FibroBiologics to manufacture the company’s spheroids for clinical trials in multiple sclerosis (MS) and several other conditions. The spheroids are groups of fibroblast cells arranged in a three-dimensional (3D) structure that more closely resemble how cells organize in living tissues.
May 2, 2024 Columns by Benjamin Hofmeister There’s comfort in putting a name to a multiple sclerosis symptom I feel like I’ve been in this exact place, saying exactly what I’m saying right now. Have I done this in a past life? Did I dream it and am now subconsciously acting it out in reality? Or is my brain performing a fact-check on its memory system and signaling…